Table 3.
Patient | Age (years) and sex | Diff | EBV type | NISH | LMP | EBNA | 30 bp | |
1 | 72 | M | W | − | − | − | − | − |
2 | 66 | F | W | − | − | − | − | − |
3 | 70 | M | W | − | − | − | − | − |
4 | 74 | F | W | − | − | − | − | − |
5 | 60 | M | W | A | + | + | + | + |
6 | 56 | M | W | A | + | + | + | + |
7 | 87 | F | W | A | + | + | + | + |
8 | 68 | M | W | − | − | − | − | − |
9 | 78 | F | W | − | − | − | − | − |
10 | 71 | M | M | − | − | − | − | − |
11 | 74 | F | M | − | − | − | − | − |
12 | 79 | F | M | − | − | − | − | − |
13 | 77 | M | M | − | − | − | − | − |
14 | 72 | M | M | − | − | − | − | − |
15 | 56 | M | M | − | − | − | − | − |
16 | 50 | M | M | − | − | − | − | − |
17 | 84 | F | M | − | − | − | − | − |
18 | 59 | M | M | − | − | − | − | − |
19 | 63 | M | M | − | − | − | − | − |
20 | 55 | F | P | A | + | + | + | + |
Diff, degree of the histological differentiation of the tumour: M, moderately differentiated; P, poorly differentiated; W, well differentiated. NISH, non-isotopic in situ hybridisation of EBV encoded RNA 1; LMP, immunohistochemical demonstration of latent membrane protein 1 antigen; EBNA, immunohistochemical demonstration of the EBV nuclear antigen 2; 30 bp, 30 bp deletion of LMP-1.